Complete response to topotecan of recurrent fallopian tube carcinoma.
To describe the first complete response of recurrent Fallopian tube carcinoma to topotecan. A patient with recurrent Fallopian tube carcinoma previously treated with paclitaxel (Taxol) and carboplatin is described. This patient demonstrated a complete clinical response to topotecan. Radiographic and CA-125 measurements were used to determine response. Response was noted after four cycles and a complete response demonstrated after six treatments. Topotecan appears active in recurrent Fallopian tube carcinoma.